Yahoo Web Search

Search results

1. • 

     Earnings call: GSK forecasts growth with strong Q1 performance By Investing.com

     Investing.com· 1 day ago

     GSK upgraded its full-year guidance, expecting another year of substantial growth for shareholders,...

2. • Q1 2024 Exelixis Inc Earnings Call

     Thomson Reuters StreetEvents via Yahoo Finance· 4 days ago

     This increase in gross to net deductions in the first quarter of 2024 is primarily related to higher Medicare Part D and PHS expenses ...

3. • 

     Novo Nordisk earnings are coming during a weight loss drugs sales surge. Here are 3 things to watch

     Quartz· 5 days ago

     Novo Nordisk, the maker of the mega-popular diabetes and weight loss medications Ozempic and Wegovy,...

4. • 

     Goldman Scrutinizes Hits, Misses, And Growth Trajectory Concerns For Eli Lilly And Its Its Obesity...

     Benzinga· 5 days ago

     Tuesday, Eli Lilly And Co LLY reported first-quarter revenue of $8.77 billion, up 26% year over...

5. • 

     Unveiling Cigna (CI) Q1 Outlook: Wall Street Estimates for Key Metrics

     Zacks via Yahoo Finance· 6 days ago

     Besides Wall Street's top -and-bottom-line estimates for Cigna (CI), review projections for some of...

6. • 'Miracle' weight-loss drugs could have reduced health disparities. Instead they got worse

     The Day· 4 days ago

     The American Heart Association calls them "game changers." Oprah Winfrey says they're "a gift." Americans are most familiar with their brand names: Ozempic, Wegovy, Mounjaro, Zepbound. Obesity ...

7. • 

     ‘The right people:’ Florida man gets free financial lifeline he never knew existed

     WKMG ClickOrlando· 4 days ago

     Donnie Graham, a 77-year-old Florida retiree on a fixed income, found himself in need of a place to...

8. • 

     Earnings call: GSK forecasts growth with strong Q1 performance

     Investing.com· 2 days ago

     GSK (GSK) reported robust earnings for the first quarter, with a 13% increase in sales to £7.4...

9. • 

     Earnings call: Astellas Pharma exceeds revenue forecast, faces profit dip

     Investing.com· 7 days ago

     Astellas Pharma Inc. (ALPMY) reported a surpassing of its full-year revenue forecast for FY 2023,...

10. • 

      Earnings call: Astellas Pharma exceeds revenue forecast, faces profit dip By Investing.com

      Investing.com· 6 days ago

      Astellas Pharma Inc. (ALPMY) reported a surpassing of its full-year revenue forecast for FY 2023,...